Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer

A Farolfi, L Calderoni, F Mattana, R Mei… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer
(PCa) cells, and several PSMA ligands for PET imaging are now available worldwide. 68Ga …

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics

V Liberini, R Laudicella, M Balma, DG Nicolotti… - European radiology …, 2022 - Springer
In prostate cancer (PCa), the use of new radiopharmaceuticals has improved the accuracy of
diagnosis and staging, refined surveillance strategies, and introduced specific and …

[PDF][PDF] 中国前列腺癌筛查与早诊早治指南(2022, 北京).

赫捷, 陈万青, 李霓, 曹巍, 叶定伟, 马建辉… - Chinese Journal of …, 2022 - jhxrmyy.com
前列腺癌是好发于老年男性的生殖系统恶性肿瘤. 前列腺癌高风险人群筛查与患者的早诊早治对
提高前列腺癌治愈率至关重要. 制定符合中国国情的前列腺癌筛查与早诊早治指南 …

Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: An explorative study on machine learning feature …

P Alongi, A Stefano, A Comelli, R Laudicella… - European …, 2021 - Springer
Objective The aim of this study was (1) to investigate the application of texture analysis of
choline PET/CT images in prostate cancer (PCa) patients and (2) to propose a machine …

Amino acid PET in neurooncology

N Galldiks, P Lohmann, GR Fink… - Journal of Nuclear …, 2023 - Soc Nuclear Med
For decades, several amino acid PET tracers have been used to optimize diagnostics in
patients with brain tumors. In clinical routine, the most important clinical indications for amino …

Non-conventional and investigational PET radiotracers for breast cancer: a systematic review

M Balma, V Liberini, M Racca, R Laudicella… - Frontiers in …, 2022 - frontiersin.org
Breast cancer is one of the most common malignancies in women, with high morbidity and
mortality rates. In breast cancer, the use of novel radiopharmaceuticals in nuclear medicine …

Molecular imaging in primary staging of prostate cancer patients: current aspects and future trends

R Manafi-Farid, S Ranjbar, Z Jamshidi Araghi, J Pilz… - Cancers, 2021 - mdpi.com
Simple Summary Accurate primary staging for determining the extent of prostate cancer is
crucial for planning treatment in high-risk patients for distant metastases. Recurrence is still …

Diagnostic performance of PET imaging using different radiopharmaceuticals in prostate cancer according to published meta-analyses

S Annunziata, DA Pizzuto, G Treglia - Cancers, 2020 - mdpi.com
A significant number of meta-analyses reporting data on the diagnostic performance of
positron emission tomography (PET) in prostate cancer (PCa) is currently available in the …

18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas

D Albano, D Tomasini, M Bonù, R Giubbini… - Annals of Nuclear …, 2020 - Springer
Abstract 18 F-fluciclovine (18 F-FACBC) is a radiotracer already studied for prostate cancer,
and its potential role in brain tumors (such as glioma) is not yet well investigated despite …

Prostate Cancer Biochemical Recurrence Resulted Negative on [68Ga]Ga-PSMA-11 but Positive on [18F]Fluoromethylcholine PET/CT

R Laudicella, F La Torre, V Davì, L Crocè, D Aricò… - Tomography, 2022 - mdpi.com
For prostate cancer (PCa) biochemical recurrence (BCR), the primarily suggested imaging
technique by the European Association of Urology (EAU) guidelines is prostate-specific …